Scyllo-Inositol

CAS No. 488-59-5

Scyllo-Inositol( Scyllitol )

Catalog No. M21272 CAS No. 488-59-5

Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 51 In Stock
50MG 157 In Stock
100MG 262 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scyllo-Inositol
  • Note
    Research use only, not for human use.
  • Brief Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Scyllitol
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    amyloid-β
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer's Disease

Chemical Information

  • CAS Number
    488-59-5
  • Formula Weight
    180.16
  • Molecular Formula
    C6H12O6
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:5 mg/mL (27.75 mM; Need ultrasonic)
  • SMILES
    O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ibrahim T Mclaurin J A . α-Synuclein aggregation seeding and inhibition by scyllo-inositol[J]. Biochemical & Biophysical Research Communications 2015:S0006291X15310482.
molnova catalog
related products
  • DSS30

    DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).

  • MAO-B-IN-9

    MAO-B-IN-9 is a monoamine oxidase B MAO-B inhibitor (IC50: 0.18 μM) that crosses the blood-brain barrier with potency, selectivity and time-dependence.

  • Buntanetap

    Buntanetap ((+)-Phenserine) is an orally active inhibitor of polyneurotoxic proteins (TINAPs) for the study of neurological disorders, endocrine and metabolic disorders, and cardiovascular diseases.